Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
790 participants
OBSERVATIONAL
2009-10-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
NCT00321217
Genetic Registry for Rheumatoid Arthritis
NCT00069472
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291
Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset
NCT05808309
Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity
NCT05570513
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rheumatoid Arthritis
Patients with rheumatoid arthritis
No interventions assigned to this group
Healthy controls
Healthy control subjects
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Slovak Academy of Sciences
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stefan Zorad
Head of Laboratory
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Imrich
Role: STUDY_CHAIR
Slovak Academy of Sciences, Center for Molecular Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Slovak Academy of Sciences, Center for Molecular Medicine
Bratislava, , Slovakia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ATMOS N00024
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
RASGENAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.